NM_000939.4:c.668T>C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_000939.4(POMC):c.668T>C(p.Met223Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,613,112 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_000939.4 missense
Scores
Clinical Significance
Conservation
Publications
- obesity due to pro-opiomelanocortin deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
- inherited obesityInheritance: SD, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POMC | NM_000939.4 | c.668T>C | p.Met223Thr | missense_variant | Exon 3 of 3 | ENST00000395826.7 | NP_000930.1 | |
POMC | NM_001035256.3 | c.668T>C | p.Met223Thr | missense_variant | Exon 4 of 4 | NP_001030333.1 | ||
POMC | NM_001319204.2 | c.668T>C | p.Met223Thr | missense_variant | Exon 4 of 4 | NP_001306133.1 | ||
POMC | NM_001319205.2 | c.668T>C | p.Met223Thr | missense_variant | Exon 3 of 3 | NP_001306134.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 151886Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250566 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461226Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726934 show subpopulations
GnomAD4 genome AF: 0.000138 AC: 21AN: 151886Hom.: 0 Cov.: 33 AF XY: 0.0000944 AC XY: 7AN XY: 74170 show subpopulations
ClinVar
Submissions by phenotype
POMC-related disorder Uncertain:1
The POMC c.668T>C variant is predicted to result in the amino acid substitution p.Met223Thr. This variant was reported in the heterozygous state in a patient with severe obesity (Courbage et al. 2021. PubMed ID: 34097736). It was also observed in a cohort of obese individuals, and in vitro functional studies show strong evidence of loss of function (Table 3 and Supplemental Data Set, Shah et al. 2023. PubMed ID: 36864747). This variant is reported in 0.052% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at